NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics revenues increased 7 percent year over year, surpassing the overall growth of the firm's diagnostics division.

The Swiss drugs, diagnostics, and research products giant reported total diagnostics sales of CHF 10.27 billion $11.22 billion), up 5 percent from CHF 9.74 billion in 2011. On a constant currency basis, revenues were up 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.